RecruitingNot ApplicableNCT06847061

Pulmonary Rehabilitation for Rural Patients With COPD

Decreasing Disparity in Lung Disease: Pulmonary Rehabilitation for Rural Patients With COPD

Sponsor

Mayo Clinic

Enrollment

306 participants

Start Date

Apr 1, 2025

Study Type

INTERVENTIONAL

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Summary

The purpose of this study is to test the uptake, effectiveness, and patient-caregiver-provider experience of a crucial treatment not provided in rural areas: pulmonary rehabilitation.

Eligibility

Min Age: 40 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a pulmonary rehabilitation program (structured exercise and breathing education) delivered to people with COPD (a chronic lung disease) who live in rural areas and have limited access to in-person care. **You may be eligible if...** - You are 40 years of age or older - You have been diagnosed with COPD by a doctor - You live in a rural area (as defined by Rural-Urban Commuting Area codes 4 through 10) - You experience at least mild breathlessness during your daily activities - You speak English **You may NOT be eligible if...** - You are unable to walk due to an orthopedic, neurological, or heart condition - You have significant cognitive difficulties that would prevent participation Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALPulmonary rehabilitation program

Participants are expected to engage in the home-based pulmonary rehabilitation routine at least 24 minutes a day, five to six days a week for the entire 12-week study period. The pulmonary rehabilitation routine begins with slow upper body and timed breathing exercises, followed by two slow balance walks for 6 minutes each. The total exercise time again is 24 minutes, followed by a 4-minute mindful breathing meditation/cool down

Locations(2)

Mayo Clinic in Arizona

Scottsdale, Arizona, United States

Mayo Clinic in Rochester

Rochester, Minnesota, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06847061

Related Trials

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

NCT06878261268 locations

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

NCT06883305301 locations

Impact of Eradication Therapy on Helicobacter Pylori Infection With Chronic Obstructive Pulmonary Disease:

NCT075748791 location

Study of Patient With Frequent Exacerbations in Moscow

NCT073077811 location

Long-term Real-world Study of Dupilumab in COPD : Patient Characteristics, Safety and Patient-reported Outcomes

NCT0738071122 locations